You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Bioresorbable vascular scaffold

Showing 1 - 25 of 7,577
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Bioresorbable Vascular Scaffold in Routine Clinical Practice

Active, not recruiting
  • Arterial Occlusive Diseases
  • +3 more
  • Bioresorbable Vascular Scaffold
  • Seoul, Songpa-gu, Korea, Republic of
  • +13 more
Dec 11, 2022

Coronary Artery Disease Trial (MeRes 100 Sirolimus-eluting Bioresorbable Vascular Scaffold System (BRS))

Not yet recruiting
  • Coronary Artery Disease
  • MeRes 100 Sirolimus-eluting Bioresorbable Vascular Scaffold System (BRS)
  • (no location specified)
Jun 10, 2022

Critical Limb Ischemia Trial in Saint Helena, Leipzig (MOTIV Sirolimus-Eluting Bioresorbable Scaffold, Percutaneous Transluminal

Recruiting
  • Critical Limb Ischemia
  • MOTIV Sirolimus-Eluting Bioresorbable Scaffold
  • Percutaneous Transluminal Angioplasty (PTA) Device
  • Saint Helena, California
  • +1 more
Oct 19, 2022

Coronary Artery Disease Trial in Fribourg (Implantation of everolimus-eluting bioresorbable vascular scaffold stent,

Completed
  • Coronary Artery Disease
  • Implantation of everolimus-eluting bioresorbable vascular scaffold stent
  • +2 more
  • Fribourg, Switzerland
    Fribourg Cantonal Hospital
Oct 14, 2021

IRIS-BVS AMI Registry

Terminated
  • Arterial Occlusive Diseases
  • +2 more
  • Bioresorbable Vascular Scaffold
  • Seoul, Korea, Republic of
    Asan Medical Center
Sep 6, 2021

Cardiac Allograft Vasculopathy Trial in Italy, Netherlands (Everolimus-Eluting Bioresorbable Vascular Scaffold (ABSORB))

Completed
  • Cardiac Allograft Vasculopathy
  • Everolimus-Eluting Bioresorbable Vascular Scaffold (ABSORB)
  • Cagliari, Italy
  • +9 more
Sep 29, 2021

Coronary Artery Disease Trial in Kunming (Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System (IBS), Abbott Vascular

Recruiting
  • Coronary Artery Disease
  • Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System (IBS)
  • Abbott Vascular XIENCE Everolimus Eluting Coronary Stent System
  • Kunming, China
    Fuwai Yunnan Cardiovascular Hospital
Mar 16, 2022

Chronic Limb-Threatening Ischemia Trial (MAGNITUDE Sirolimus-eluting Bioresorbable Scaffold, Percutaneous Transluminal

Not yet recruiting
  • Chronic Limb-Threatening Ischemia
  • MAGNITUDE Sirolimus-eluting Bioresorbable Scaffold
  • Percutaneous Transluminal Angioplasty (PTA)
  • (no location specified)
Oct 9, 2023

Coronary Artery Stenosis Trial in Austria, Germany (ABSORB Scaffold)

Completed
  • Coronary Artery Stenosis
  • ABSORB Scaffold
  • Vienna, Wien, Austria
  • +80 more
Mar 31, 2022

Peripheral Arterial Disease, Critical Limb Ischemia Trial in Austria, Germany (MOTIV BVS)

Active, not recruiting
  • Peripheral Arterial Disease
  • Critical Limb Ischemia
  • MOTIV BVS
  • Vienna, Austria
  • +7 more
Aug 30, 2021

Critical Limb-Threatening Ischemia, Critical Limb Ischemia, Critical Lower Limb Ischemia Trial (MAGNITUDE BRS)

Not yet recruiting
  • Critical Limb-Threatening Ischemia
  • +2 more
  • MAGNITUDE BRS
  • (no location specified)
Oct 4, 2023

Critical Limb Ischemia Trial in Singapore (BVS, Abbott Vascular)

Completed
  • Critical Limb Ischemia
  • BVS, Abbott Vascular
  • Singapore, Singapore
    Changi General Hospital
Oct 6, 2020

Infrapopliteal Lesions, Critical Limb Ischemia Trial in Florence (Sirolimus-eluting Iron Bioresorbable Peripheral Scaffold

Recruiting
  • Infrapopliteal Lesions
  • Critical Limb Ischemia
  • Sirolimus-eluting Iron Bioresorbable Peripheral Scaffold System (IBS Titan™)
  • Florence, Italy
    Azienda Ospedaliero Universitaria Careggi
Jul 31, 2023

Coronary Artery Disease, Ischemic Heart Disease, Stable Angina Trial in Ulm (use of bioresorbable vascular scaffolds)

Completed
  • Coronary Artery Disease
  • +4 more
  • use of bioresorbable vascular scaffolds
  • Ulm, Germany
    University of Ulm
Apr 25, 2020

Patients Treated With Bioresorbable Vascular Scaffolds

Withdrawn
  • Coronary Artery Disease
  • Bioresorbable Vascular Scaffold
  • Drug Eluting Stent
  • Falls Church, Virginia
    Inova Fairfax Hospital
Jun 12, 2020

Coronary Artery Disease Trial in Kunming (Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System)

Recruiting
  • Coronary Artery Disease
  • Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System
  • Kunming, Yunnan, China
    Fuwai Yunnan Cardiovascular Hospital
Mar 16, 2022

STEMI Trial in Brussels (the ABSORB:bioresorbable vascular scaffold, O.M.T)

Completed
  • STEMI
  • the ABSORB:bioresorbable vascular scaffold
  • O.M.T
  • Brussels, Belgium
    StLuc
May 4, 2020

Coronary Occlusion Trial in Bern (OCT-guided PCI, Angiography-guided PCI)

Terminated
  • Coronary Occlusion
  • OCT-guided PCI
  • Angiography-guided PCI
  • Bern, Switzerland
    Inselspital Bern
Feb 23, 2022

Coronary Artery Disease, Stable Angina, Coronary Artery Stenosis Trial in Odense (ScoreFlex balloon, Device: standard

Recruiting
  • Coronary Artery Disease
  • +9 more
  • ScoreFlex balloon
  • Device: standard non-compliant balloon
  • Odense, Denmark
    Odense University Hospital
Nov 30, 2021

Single Coronary Vessel Disease Trial in Peking (Sirolimus-eluting Iron Bioresorbable Coronary Scaffold System)

Active, not recruiting
  • Single Coronary Vessel Disease
  • Sirolimus-eluting Iron Bioresorbable Coronary Scaffold System
  • Peking, China
    Beijing Fuwai hospital
Sep 10, 2021

Peripheral Arterial Disease, Vascular Diseases, Stenosis Trial in Auckland (Efemoral Vascular Scaffold System (EVSS))

Recruiting
  • Peripheral Arterial Disease
  • +3 more
  • Efemoral Vascular Scaffold System (EVSS)
  • Auckland, New Zealand
    Auckland City Hospital
Mar 31, 2022

Patients Who Are Scheduled to Undergo a PCI (Percutaneous Coronary Intervention) for CTO (Chronic Total Occlusion) Trial in

Completed
  • Patients Who Are Scheduled to Undergo a PCI (Percutaneous Coronary Intervention) for CTO (Chronic Total Occlusion)
  • Hospitalet de Llobregat, Barcelona, Spain
  • +1 more
Dec 18, 2019

Coronary Artery Disease Trial in Brussels (Abbott Vascular XIENCE Everolimus Eluting Coronary Stent System, Abbott Vascular

Completed
Has Results
  • Coronary Artery Disease
  • Abbott Vascular XIENCE Everolimus Eluting Coronary Stent System
  • Abbott Vascular ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold System
  • Brussels, Belgium
    Abbott Vascular International BVBA
Nov 8, 2019

Coronary Artery Disease, Coronary Artery Stenosis, Coronary Disease Trial in Santa Clara (XIENCE V EECSS, Absorb BVS System)

Completed
Has Results
  • Coronary Artery Disease
  • +3 more
  • XIENCE V EECSS
  • Absorb BVS System
  • Santa Clara, California
    Abbott Vascular
Nov 12, 2019

Acute Coronary Syndrome Trial in Toulouse (SYNERGY stent, ABSORB (Everolimus-eluting Bioresorbable Vascular Scaffold))

Completed
  • Acute Coronary Syndrome
  • SYNERGY stent
  • ABSORB (Everolimus-eluting Bioresorbable Vascular Scaffold)
  • Toulouse, France
    Didier CARRIE
Aug 19, 2019